Atherectomy Devices Market Share

Atherectomy Devices Market Overview

In addition, the global atherectomy devices market is expected to reach USD 0.84 billion by 2032 at 12.1% CAGR during the forecast period 2023-2032. Global Atherectomy devices refer to various minimally invasive instruments used for peripheral vascular intervention procedures. 

They are designed to re-establish blood flow in the arteries by drilling, grinding, shaping, sanding, and to vaporize plaque, calcifying lesions and excessive cellular material. Some commonly used atherectomy devices include direction, orbital, photo-ablative, rotational, and support. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.

Atherectomy Devices Market Trends

The increasing prevalence of peripheral artery disease, atherosclerosis, diabetes and obesity and the rising geriatric population across the globe represent the key factors driving the market's growth. Furthermore, the growing preference for atherectomy surgical procedures among patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons, are acting as other growth-inducing factors. The drug-coated balloons are used in place of permanent implants with directional atherectomy and anti-restenosis therapy to deliver antiproliferative drugs and treat lesions with severe calcifications.

Atherectomy Devices Market Segment Insights

The atherectomy devices market is segmented on the basis of product type, application, and end user.

Atherectomy Devices Product Type Insights

The atherectomy devices market, by product type is categorised into directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems, and others.

The directional atherectomy systems segment is expected to hold the largest share owing to the high treatment rate, whereas the photo-ablative (laser) atherectomy systems is expected to be the fastest growing segment owing to the growing preference by surgeons.

Based on application, the atherectomy devices market is segmented into cardiovascular, neurovascular, peripheral vascular, and others.

Atherectomy Devices End User Insights

On the basis of end user, the market is segmented into hospitals, ambulatory surgery centers, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The market of atherectomy devices in the Middle East and Africa has been segmented into the Middle East and Africa.

Atherectomy Devices Regional Insights

It is projected that the Americas dominated the atherectomy devices market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end atherectomy devices among medical professionals. Europe is expected to hold the second largest share in the market owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the market. Asia-Pacific was projected to be the fastest growing region for the market. This owes to the technological advancements resulting in the development of cost-effective atherectomy devices leading to high acceptance rate for the devices in the Asia-Pacific region. The Middle East and Africa holds the least share in the market due to the presence of economically diverse countries, and less initiatives taken by the government.

Atherectomy devices market, Key Players

• Abbott


• Avinger


• Braun Melsungen AG


• Biomerics


• Biotronik


• Boston Scientific Corporation


• R. Bard


• Cardinal Health


• Koninklijke Philips


• Minnetronix, Inc.


• Straub Medical

Atherectomy Devices Market Segmentation

Atherectomy Devices Product Type Outlook

• Directional Atherectomy Systems


• Orbital Atherectomy Systems


• Photo-Ablative (Laser) Atherectomy Systems


• Rotational Atherectomy Systems


• Others

Atherectomy Devices Application Outlook

• Cardiovascular


• Neurovascular


• Peripheral Vascular


• Others

Atherectomy Devices End User Outlook

• Hospitals


• Ambulatory Surgery Centers


• Others

Atherectomy Devices Regional Outlook

• 
  
  Middle East
  
  


• 
  
  Africa
  
  

Recent Development

October 2023, Medtronic announces the launch of its new LithoClear™ Laser Atherectomy System. The LithoClear system is designed to provide physicians with a safe and effective way to treat patients with coronary artery disease (CAD).Boston Scientific announces the launch of its new Innova™ Directional Atherectomy System. The Innova system is designed to provide physicians with a precise and controlled way to remove plaque from arteries.Philips Healthcare announces the launch of its new AngioSculpt™ Rotational Atherectomy System. The AngioSculpt system is designed to provide physicians with a powerful and versatile way to treat a variety of arterial blockages.

September 2023, A new study published in the Journal of the American Medical Association (JAMA) finds that atherectomy devices are safe and effective for treating CAD. The study found that atherectomy devices were associated with a significant reduction in the risk of major adverse cardiovascular events (MACE).Another study published in the journal Circulation: Cardiovascular Interventions finds that atherectomy devices are effective for treating patients with peripheral artery disease (PAD). The study found that atherectomy devices were associated with a significant improvement in blood flow to the legs.

Intended Audience

• Medical device companies


• Biopharmaceutical companies


• Government institutions


• Research and Development (R&D) companies


• Medical research laboratories